SPC524
Lecanemab
Status:
UmsóknApplication date:
29.8.2025Application published:
15.9.2025
Next due date:
31.3.2027Medicine name:
LEQEMBIMedicine for children:
No
Timeline
Today
29.8.2025Application
15.9.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1891Date:
15.4.2025
Owner
Name:
BioArctic ABAddress:
Warfvinges väg 39, 112 51 Stockholm SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2004688